These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28492833)

  • 21. Management of glucocorticoid-induced osteoporosis: What is new?
    Compston J
    Int J Rheum Dis; 2019 Sep; 22(9):1595-1597. PubMed ID: 31478605
    [No Abstract]   [Full Text] [Related]  

  • 22. Is too much intervention recommended in the ACP osteoporosis treatment guidelines?
    Alonso-Coello P; López A; Pencille LJ; Montori VM
    Ann Intern Med; 2009 Feb; 150(4):285-6; author reply 286-7. PubMed ID: 19221388
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial.
    Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
    J Intern Med; 2019 Aug; 286(2):221-229. PubMed ID: 30887607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
    ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Pignone M; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2018 Jun; 319(24):2521-2531. PubMed ID: 29946735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 26. Fracture prevention in osteoporosis: assessing risks, providing solutions.
    Reginster JY; Brandi ML
    Osteoporos Int; 2010 Jun; 21 Suppl 2():S401-2. PubMed ID: 20464372
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.
    Grover M; Bachrach LK
    Curr Osteoporos Rep; 2017 Aug; 15(4):271-282. PubMed ID: 28620868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
    Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
    Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence with medications used to treat osteoporosis: behavioral insights.
    Schousboe JT
    Curr Osteoporos Rep; 2013 Mar; 11(1):21-9. PubMed ID: 23334573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing and Treating Osteoporosis.
    Berry ME
    Radiol Technol; 2019 Jan; 90(3):286-293. PubMed ID: 30635461
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 33. [Medical treatment of osteoporosis in men].
    Eiken PA; Vestergaard P
    Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
    Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
    Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Process in development of PTH, an awaited bone-density conservation agent].
    Sugimoto T
    Clin Calcium; 2012 Mar; 22(3):307. PubMed ID: 22893932
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Saito T; Sterbenz JM; Malay S; Zhong L; MacEachern MP; Chung KC
    Osteoporos Int; 2017 Dec; 28(12):3289-3300. PubMed ID: 28770272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment approaches to osteoporosis - 2013.
    Honig S; Rajapakse CS; Chang G
    Bull Hosp Jt Dis (2013); 2013; 71(3):184-8. PubMed ID: 24151942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases.
    Lewiecki EM; Bilezikian JP; Bukata SV; Camacho P; Clarke BL; McClung MR; Miller PD; Shepherd J
    J Clin Densitom; 2017; 20(2):134-152. PubMed ID: 28185765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.